Curt R. Hartman - Sep 15, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role: President, CEO and Chair, Director
Signature: /s/ Daniel S. Jonas for Curt R. Hartman by Power of Attorney
Stock symbol: CNMD
Transactions as of: Sep 15, 2021
Transactions value $: -$3,020,233
Form type: 4
Date filed: 9/17/2021, 04:42 PM
Previous filing: Jun 4, 2021
Next filing: Mar 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Sale	-$318K	-2.5K	-3.7%	$127.39	65K	Sep 15, 2021	Direct	F1
transaction	CNMD	Common Stock	Options Exercise	$1.36M	+34K	+52.32%	$39.87	99K	Sep 15, 2021	Direct
transaction	CNMD	Common Stock	Tax liability	-$2.46M	-19.3K	-19.55%	$127.24	79.6K	Sep 15, 2021	Direct
transaction	CNMD	Common Stock	Options Exercise	$1.99M	+47.5K	+59.65%	$41.93	127K	Sep 15, 2021	Direct
transaction	CNMD	Common Stock	Tax liability	-$3.59M	-28.2K	-22.17%	$127.28	98.9K	Sep 15, 2021	Direct
transaction	CNMD	Common Stock	Gift	$0	-89K	-89.95%	$0.00	9.95K	Sep 17, 2021	Direct	F2
transaction	CNMD	Common Stock	Gift	$0	+89K		$0.00	89K	Sep 17, 2021	Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Options To Purchase Common Stock	Options Exercise	$0	-34K	-100%	$0.00^*	0	Sep 15, 2021	Common Stock	34K	$39.87	Direct	F3
transaction	CNMD	Options To Purchase Common Stock	Options Exercise	$0	-47.5K	-29.85%	$0.00	112K	Sep 15, 2021	Common Stock	47.5K	$41.93	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2	This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
F3	The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.